Trial Profile
The effects of Nebivolol/HCTZ on Central Arterial Pressure, a randomised double-blind cross-over trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2013
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Hydrochlorothiazide; Metoprolol
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms NeMeCAP
- Sponsors Menarini Benelux
- 17 Jun 2013 Primary endpoint 'Central-systolic-blood-pressure' has not been met.
- 17 Jun 2013 Primary endpoint 'Blood-pressure' has not been met.
- 17 Jun 2013 Primary endpoint 'Augmentation-index' has not been met.